• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Intravascular Catheter Market

    ID: MRFR/MED/6494-HCR
    160 Pages
    Kinjoll Dey
    October 2025

    Intravascular Catheter Market Research Report Information by Product (Short PIVC Catheters and Integrated/Closed PIVC Catheters), Application (Renal Disease, Cancer, Gastrointestinal Diseases, Infectious Diseases and other Diseases), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Intravascular Catheter Market Infographic
    Purchase Options

    Intravascular Catheter Market Summary

    As per MRFR analysis, the Intravascular Catheter Market Size was estimated at 10.11 USD Billion in 2024. The Intravascular Catheter industry is projected to grow from 10.93 USD Billion in 2025 to 23.7 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 8.05 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Intravascular Catheter Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

    • North America remains the largest market for intravascular catheters, driven by advanced healthcare infrastructure and high patient volumes.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing investments in healthcare and rising patient populations.
    • Short Peripheral Intravenous Catheters dominate the market, while Integrated/Closed PIVC Catheters are experiencing rapid growth due to their enhanced safety features.
    • Key market drivers include technological advancements and a rising focus on patient safety and quality of care, particularly in the context of chronic diseases.

    Market Size & Forecast

    2024 Market Size 10.11 (USD Billion)
    2035 Market Size 23.7 (USD Billion)
    CAGR (2025 - 2035) 8.05%

    Major Players

    Becton Dickinson and Company (US), Medtronic plc (IE), Boston Scientific Corporation (US), Smiths Medical (US), Teleflex Incorporated (US), Terumo Corporation (JP), Cardinal Health, Inc. (US), Abbott Laboratories (US)

    Intravascular Catheter Market Trends

    The Intravascular Catheter Market is currently experiencing a notable transformation, driven by advancements in technology and increasing demand for minimally invasive procedures. The growing prevalence of chronic diseases necessitates the use of intravascular catheters for effective treatment and management. Furthermore, the rising geriatric population is contributing to the market's expansion, as older individuals often require more medical interventions. Innovations in catheter design, materials, and safety features are enhancing patient outcomes and reducing complications, which appears to be a key focus for manufacturers. In addition, regulatory bodies are increasingly emphasizing safety standards and guidelines for catheter usage, which may influence market dynamics. The integration of smart technologies, such as sensors and connectivity features, is also gaining traction, potentially improving monitoring and patient care. As healthcare providers seek to enhance efficiency and patient satisfaction, the Intravascular Catheter Market is poised for continued growth, reflecting broader trends in the medical device industry.

    Technological Advancements

    The Intravascular Catheter Market is witnessing a surge in technological innovations, particularly in catheter design and materials. Manufacturers are focusing on developing products that enhance safety and reduce the risk of complications. This trend indicates a shift towards more sophisticated devices that cater to the evolving needs of healthcare providers.

    Rising Demand for Minimally Invasive Procedures

    There is an increasing preference for minimally invasive procedures among healthcare professionals and patients alike. This trend is likely to drive the demand for intravascular catheters, as they facilitate effective treatment with reduced recovery times. The market appears to be adapting to this shift by offering a wider range of catheter options.

    Focus on Patient Safety

    Patient safety remains a paramount concern in the healthcare sector. The Intravascular Catheter Market is responding to this by prioritizing the development of safer devices. Enhanced safety features, such as improved insertion techniques and infection prevention measures, are becoming more prevalent, reflecting a broader commitment to patient well-being.

    The Global Intravascular Catheter Market is poised for growth, driven by advancements in technology and increasing demand for minimally invasive procedures, which may enhance patient outcomes and streamline healthcare delivery.

    U.S. Food and Drug Administration (FDA)

    Intravascular Catheter Market Drivers

    Expansion of Healthcare Infrastructure

    The Intravascular Catheter Market is benefiting from the expansion of healthcare infrastructure in various regions. As countries invest in improving their healthcare systems, the availability of advanced medical technologies, including intravascular catheters, is increasing. This expansion is particularly evident in emerging markets, where healthcare facilities are being upgraded to meet rising patient demands. Enhanced access to healthcare services is likely to drive the adoption of intravascular catheters, as more facilities incorporate these devices into their treatment protocols. Projections indicate that this trend could lead to a significant increase in market penetration, potentially resulting in a multi-billion dollar growth trajectory for the industry in the coming years.

    Growing Prevalence of Chronic Diseases

    The Intravascular Catheter Market is significantly influenced by the growing prevalence of chronic diseases, such as diabetes and cardiovascular disorders. These conditions often necessitate frequent medical interventions, including the use of intravascular catheters for drug administration and monitoring. As the global population ages, the incidence of chronic diseases is expected to rise, thereby increasing the demand for effective catheter solutions. Market analysts project that the rise in chronic disease cases could lead to a substantial uptick in catheter utilization, with estimates suggesting that the market could expand by several billion dollars over the next decade as healthcare systems adapt to these changing needs.

    Focus on Patient Safety and Quality of Care

    The Intravascular Catheter Market is increasingly prioritizing patient safety and quality of care. Healthcare institutions are implementing stringent protocols to minimize the risks associated with catheter use, such as infections and thrombosis. This focus is driving the development of advanced catheters designed with safety features, such as retractable needles and integrated safety mechanisms. Regulatory bodies are also emphasizing the importance of safety standards, which could lead to increased compliance costs for manufacturers. However, this heightened focus on safety is likely to foster innovation within the industry, as companies strive to meet these standards while enhancing the overall quality of care provided to patients.

    Rising Demand for Minimally Invasive Procedures

    The Intravascular Catheter Market is witnessing a notable increase in the demand for minimally invasive procedures. Patients and healthcare providers alike are gravitating towards techniques that promise reduced recovery times and lower risks of complications. This trend is particularly evident in surgical settings where intravascular catheters are utilized for various applications, including drug delivery and fluid management. The shift towards outpatient care models further propels this demand, as patients prefer procedures that allow for quicker discharge. Market data suggests that the minimally invasive segment is expected to account for a substantial share of the intravascular catheter market, potentially reaching a valuation of several billion dollars in the coming years.

    Technological Advancements in Intravascular Catheter Market

    The Intravascular Catheter Market is experiencing a surge in technological advancements that enhance the efficacy and safety of catheterization procedures. Innovations such as antimicrobial coatings and advanced materials are being developed to reduce infection rates and improve patient outcomes. For instance, the introduction of smart catheters equipped with sensors allows for real-time monitoring of patient vitals, which could potentially lead to timely interventions. Furthermore, the integration of imaging technologies with catheters is likely to facilitate more precise placements, thereby minimizing complications. As these technologies evolve, they are expected to drive the demand for intravascular catheters, with projections indicating a compound annual growth rate of around 6% over the next few years.

    Market Segment Insights

    By Product: Short Peripheral Intravenous Catheters (Largest) vs. Integrated/Closed PIVC Catheters (Fastest-Growing)

    The Intravascular Catheter Market shows a clear distribution of market share among its key product segments. Short Peripheral Intravenous Catheters (PIVC) dominate the segment due to their widespread use in hospitals and clinics for short-term access. These catheters are essential for administering medications and fluids, which contributes to their substantial market presence. On the other hand, Integrated/Closed PIVC Catheters are gaining traction, primarily due to their ability to minimize the risk of infections and complications, making them increasingly popular among healthcare professionals.

    Short Peripheral Intravenous Catheters (Dominant) vs. Integrated/Closed PIVC Catheters (Emerging)

    Short Peripheral Intravenous Catheters (PIVC) serve as the foundational product in the intravascular catheter market, valued for their simplicity, ease of use, and versatility. They are predominantly used for short-term infusion therapies, making them indispensable in various clinical settings. Conversely, Integrated/Closed PIVC Catheters represent an emerging technology designed to enhance patient safety and improve clinical outcomes. These catheters integrate closed systems that significantly reduce the risk of contamination and central line-associated bloodstream infections (CLABSI), aligning with the growing focus on infection control in healthcare environments.

    By Application: Renal Disease (Largest) vs. Cancer (Fastest-Growing)

    The intravascular catheter market is witnessing a diverse application distribution, with renal diseases holding a significant share due to the increasing prevalence of kidney-related ailments. Alongside, cancer treatments are experiencing a rapid adoption of intravascular devices, driven by the increasing incidences of various cancers. Other applications, such as gastrointestinal and infectious diseases, also contribute to the market landscape, presenting opportunities for growth, but they remain comparatively smaller in market share. In terms of growth trends, renal disease applications are propelled by an aging population and rising awareness of chronic illnesses. On the other hand, the cancer segment is emerging rapidly, fueled by advances in treatment methodologies and the growing focus on personalized medicine. Infectious diseases and other conditions are gradually gaining traction, though they currently possess lower growth rates in the market.

    Renal Disease: Dominant vs. Cancer: Emerging

    Renal disease applications dominate the intravascular catheter market due to the steady increase in chronic kidney diseases. This segment benefits from established treatment protocols, solidifying its market position. Conversely, the cancer segment is positioned as an emerging area driven by innovative therapeutic approaches such as immunotherapy and targeted treatments. The growing demand for continuous venous access for chemotherapy and clinical trials is bolstering this segment. Intravascular catheters tailored for cancer patients are quickly gaining importance, reflecting adaptability in technology and a patient-centered approach. As these segments evolve, renal disease remains a robust leader while cancer applications rapidly expand, indicating shifting dynamics within the market.

    By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

    The Intravascular Catheter Market exhibits a diverse distribution of shares across various end users. Hospitals hold the largest share due to a high volume of surgeries and increased patient admissions, leading to a higher demand for intravascular catheters. Clinics also contribute significantly but at a lower scale, while ambulatory surgical centers and homecare settings are gradually increasing their share as healthcare delivery shifts towards outpatient and at-home treatments. Other settings, while present, represent a smaller fraction of the overall market.

    Hospitals (Dominant) vs. Homecare (Emerging)

    Hospitals serve as the dominant end user in the intravascular catheter market, fueled by their extensive use of these devices for various medical procedures. Their infrastructure supports high patient turnover, facilitating a consistent demand for catheters. In contrast, homecare is emerging as a significant segment as more patients are treated in home environments, necessitating the use of intravascular catheters for long-term treatments. This trend is driven by technological advancements in catheter design, which have made at-home procedures safer and more efficient.

    Get more detailed insights about Intravascular Catheter Market

    Key Companies in the Intravascular Catheter Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Announces FDA Clearance of AGENT Drug-Coated Balloon Catheter for Coronary In-Stent Restenosis Boston Scientific received FDA clearance for its AGENT Drug-Coated Balloon Catheter, designed to treat coronary in-stent restenosis, marking a significant regulatory milestone in the intravascular catheter sector.
    • Q2 2024: Medtronic Launches Next-Generation HawkOne Directional Atherectomy System in Europe Medtronic announced the European launch of its updated HawkOne Directional Atherectomy System, an intravascular catheter device for treating peripheral artery disease, expanding its product portfolio in the region.
    • Q1 2024: Teleflex Receives CE Mark for Arrow Pressure Injectable Midline Catheter Teleflex announced it has received CE Mark approval for its Arrow Pressure Injectable Midline Catheter, enabling expanded use of the device in European healthcare markets.
    • Q2 2024: BD Launches New UltraSafe Peripheral IV Catheter in the United States BD introduced its UltraSafe Peripheral IV Catheter in the U.S. market, featuring enhanced safety mechanisms to reduce needlestick injuries and improve patient outcomes.
    • Q1 2024: Edwards Lifesciences Announces FDA Approval for Acumen IQ Central Venous Catheter Edwards Lifesciences received FDA approval for its Acumen IQ Central Venous Catheter, a device designed to provide advanced hemodynamic monitoring for critically ill patients.
    • Q2 2024: Smiths Medical Acquires Vascular Solutions to Expand Intravascular Catheter Portfolio Smiths Medical completed the acquisition of Vascular Solutions, strengthening its position in the intravascular catheter market and broadening its product offerings for vascular access.
    • Q1 2024: Johnson & Johnson Launches New Biosense Webster Intravascular Ultrasound Catheter Johnson & Johnson’s Biosense Webster division launched a new intravascular ultrasound (IVUS) catheter, targeting improved imaging for complex cardiovascular procedures.
    • Q2 2024: Penumbra Announces Opening of New Manufacturing Facility for Catheter Production in California Penumbra opened a new manufacturing facility in California dedicated to the production of advanced intravascular catheters, aiming to meet growing global demand.
    • Q1 2024: Abbott Receives CE Mark for Navitor Transcatheter Aortic Valve Implantation System Abbott received CE Mark approval for its Navitor TAVI system, which includes a novel delivery catheter for minimally invasive heart valve replacement procedures.
    • Q2 2024: Vascular Access Technologies Raises $40 Million in Series C Funding Vascular Access Technologies secured $40 million in Series C funding to accelerate development and commercialization of its next-generation intravascular catheter devices.
    • Q1 2024: FDA Approves Merit Medical’s Prelude IDeal Hydrophilic Sheath Introducer The FDA approved Merit Medical’s Prelude IDeal Hydrophilic Sheath Introducer, an intravascular access device designed to facilitate minimally invasive cardiovascular procedures.
    • Q2 2024: Teleflex Announces Partnership with Mayo Clinic to Develop Next-Generation Central Venous Catheters Teleflex entered into a strategic partnership with Mayo Clinic to co-develop advanced central venous catheters, focusing on reducing infection rates and improving patient safety.

    Future Outlook

    Intravascular Catheter Market Future Outlook

    The Intravascular Catheter Market is projected to grow at a 7.74% CAGR from 2024 to 2035, driven by technological advancements, increasing chronic diseases, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop smart catheters with integrated sensors for real-time monitoring.
    • Expand product lines to include biocompatible materials for enhanced patient safety.
    • Leverage telemedicine to improve catheter management and patient follow-up.

    By 2035, the Intravascular Catheter Market is expected to achieve substantial growth, reflecting advancements and increased demand.

    Market Segmentation

    Global Intravascular Catheter Market, by Region

    Americas
    Europe
    Asia-Pacific
    Middle East & Africa

    Intravascular Catheter Market Industry Developments

    Q2 2024: Boston Scientific Announces FDA Clearance of AGENT Drug-Coated Balloon Catheter for Coronary In-Stent Restenosis
    Q2 2024: Medtronic Launches Next-Generation HawkOne Directional Atherectomy System in Europe
    Q1 2024: Teleflex Receives CE Mark for Arrow Pressure Injectable Midline Catheter
    Q2 2024: BD Launches New UltraSafe Peripheral IV Catheter in the United States
    Q1 2024: Edwards Lifesciences Announces FDA Approval for Acumen IQ Central Venous Catheter
    Q2 2024: Smiths Medical Acquires Vascular Solutions to Expand Intravascular Catheter Portfolio
    Q1 2024: Johnson & Johnson Launches New Biosense Webster Intravascular Ultrasound Catheter
    Q2 2024: Penumbra Announces Opening of New Manufacturing Facility for Catheter Production in California
    Q1 2024: Abbott Receives CE Mark for Navitor Transcatheter Aortic Valve Implantation System
    Q2 2024: Vascular Access Technologies Raises $40 Million in Series C Funding
    Q1 2024: FDA Approves Merit Medical’s Prelude IDeal Hydrophilic Sheath Introducer
    Q2 2024: Teleflex Announces Partnership with Mayo Clinic to Develop Next-Generation Central Venous Catheters

    Report Scope

    Report Attribute/Metric Details
      Market Size 2023   USD 9.36 Billion
      Market Size 2024   USD 10.07 Billion
      Market Size 2032   USD 18.12 Billion
      CAGR   8.05%
      Base Year   2023
      Forecast Period   2024-2032
      Historical Data   2022
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product, Application, And End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Boston Scientific Corporation, C.R. Bard, Inc., Coloplast, Cook Medical, Edwards Life Sciences Corporation, Getinge AB, Johnson & Johnson, McKesson Medical Surgical Inc., Medtronic Inc., Smiths Medical, and Terumo Corporation
      Key Market Opportunities   Increasing number of intravascular catheterization procedures
      Key Market Drivers ·  Rising prevalence of life-threatening diseases ·  Growing demand for minimally invasive procedures to diagnose and treat different chronic diseases

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What was the valuation of the intravascular catheter market in 2030?

    The intravascular catheter market had a valuation of USD 18.12 Billion in 2032.

    What is the predicted CAGR of the intravascular catheter market during the forecast period of 2022-2030?

    The intravascular catheter market is slated to grow with a CAGR of 8.05% during the forecast period.

    Which application-based segment is leading the intravascular catheter market?

    The renal disease segment is leading the intravascular catheter market.

    Which application-based segment is expected to be the fastest-growing segment of the intravascular catheter market?

    The cancer segment can be the fastest-growing in the intravascular catheter market.

    Which region would lead the intravascular catheter market?

    The Americas would top the intravascular catheter market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions